Phosphoproteomics

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

Phosphoproteomics is the study of proteins that carry phosphate groups added after they are made. Phosphorylation acts like a reversible switch that can turn protein activity on or off, affect where a protein goes in the cell, how it forms complexes, and how signals move through cells. It’s estimated that 30–65% of proteins can be phosphorylated, and many proteins have multiple phosphorylation sites. In humans, mice, and yeast, researchers estimate roughly 230,000; 156,000; and 40,000 phosphorylation sites, respectively.

Phosphoproteomics gives two extra kinds of information beyond simply measuring protein levels. First, changes in phosphorylation usually reflect changes in protein activity, helping identify which proteins or pathways are active. Second, it highlights potential drug targets, especially kinases, the enzymes that add phosphate groups.

A typical large study starts with growing cells under different conditions and labeling them for comparison. After stimulating the cells and collecting samples at various times, proteins are chopped into peptides. Phosphopeptides are enriched using methods that selectively pull them out, such as antibodies against phosphotyrosine, immobilized metal affinity chromatography (IMAC), or titanium dioxide (TiO2) chromatography. The enriched peptides are then analyzed by mass spectrometry to identify where and how much phosphorylation has occurred.

Phosphopeptide enrichment combines several approaches to get as clean a sample as possible. Anti-phosphotyrosine antibodies work well for tyrosine phosphorylation, while IMAC and TiO2 capture serine- and threonine-phosphorylated peptides. Strong cation exchange (SCX) chromatography helps separate phosphorylated from non-phosphorylated peptides. Many studies use more than one method together.

Mass spectrometry, sometimes with isotope labeling strategies like ICAT or SILAC, is the main tool for comparing different samples and measuring changes in phosphorylation.

Kinases are the main drivers of phosphorylation, transferring phosphate from ATP to serine, threonine, or tyrosine residues. Phosphorylation can alter a protein’s activity, location, or structure, making phosphoproteomics ideal for studying signaling networks and how they change over time.

Examples show the power of this approach. Some studies measure how phosphorylation changes after a growth signal, tracking many proteins over time. In one case, 127 phosphoproteins changed, with 40 showing increased phosphorylation. In another, 714 sites on 223 proteins were identified after vasopressin in kidney cells, including new sites on the water channel aquaporin-2.

In cancer research, tumors often have distinct phosphoproteomes from normal tissue, suggesting biomarkers and potential drug targets. Phosphoproteomics could help diagnose cancers, predict outcomes, and guide therapy by revealing tumor-specific signaling patterns.

There are still challenges. Some enrichment methods don’t distinguish direct substrates from proteins that interact with phosphorylated proteins, and some phosphoproteins are too rare to detect. Sample preparation, enrichment, and instrument variability can also affect results. Even with advances, current approaches can capture about 70–95% of phosphoproteins but only 40–60% of all phosphorylation sites, even after multiple runs.